Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
Part of paid clinical trials in Detroit, Michigan.
- Sponsor
- John D. Dingell VA Medical Center
- Study ID
- NCT02922894
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Sleep Apnea
- Spinal Cord Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Accepted
Interventions
- Acute episodic hypoxia — PROCEDUREThe subjects will undergo 30 minutes of baseline monitoring followed by 15 episodes of one minute of episodic hypoxia with supplemental CO2 to maintain isocapnia. This is followed by a 45 minute recovery period.
- Supplemental oxygen — PROCEDURESupplemental oxygen therapy for 6 weeks
- Trazodone — DRUG100mg before bedtime
- Placebo — DRUGOne placebo pill before-bedtime
- Sham — PROCEDURERoom air will be administered instead of episodic hypoxia or supplemental oxygen..
Study Details
This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months post-injury).
Key Dates
- Start date
- Jun 9, 2017
- Status verified
- Mar 2025
- Primary completion
- Jan 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Experimental: Acute episodic hypoxiaTo test development of ventilatory augmentation following episodic hypoxia, defined as increased Hypoxic Ventilatory Response (HVR) from early to late hypoxic exposure episodes.
- Experimental: Supplemental oxygenTo use supplemental oxygen to decrease peripheral chemoreceptor activity in patients with SCI and central SDB. In addition, perform a repeat evaluation after treatment with supplemental oxygen or sham O2 for 6 weeks to determine if correction of chronic intermittent hypoxia, which mitigates sensory LTF, results in decreased propensity to central apnea.
- Experimental: Trazodone or placeboexamine the effect of trazodone on breathing during sleep
Primary Outcome Measure
Change in Tidal Volume [ Time Frame: 1 Week ]
Central Contacts
- M Safwan Badr, M.D.313-576-3548
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| John D. Dingell VA Medical Center | Detroit | Michigan | 48201 | M. Safwan Badr, MD 313-576-3548 |
Find similar trials in Detroit, MI
By research site
Related Studies
- Sleep Apnea in ElderlyPHASE4 · Recruiting · VA Office of Research and Development · Detroit, Michigan
- Effect of Hypercapnia Treatment on Respiratory Recovery After Spinal Cord InjuryRecruiting · VA Office of Research and Development · Detroit, Michigan
- Sleep Disordered Breathing With Opioid UsePHASE1/PHASE2 · Recruiting · VA Office of Research and Development · Detroit, Michigan
- Janus II FeasibilityRecruiting · Zoll Medical Corporation · Scottsdale, Arizona